Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine

O Stephen Ogedengbe,1 Ignatius U Ezeani,2 Ijezie I Chukwuonye,3 Ndukaife Anyabolu,4,5 Ikemefuna I Ozor,6 Aihanuwa Eregie1 1Department of Internal Medicine, University of Benin Teaching Hospital, Benin City, 2Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/26deae554b3d40eab6488ab7ac35a9c9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:26deae554b3d40eab6488ab7ac35a9c9
record_format	dspace
spelling	oai:doaj.org-article:26deae554b3d40eab6488ab7ac35a9c92021-12-02T06:37:28ZEvaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine1178-7007https://doaj.org/article/26deae554b3d40eab6488ab7ac35a9c92015-09-01T00:00:00Zhttps://www.dovepress.com/evaluating-the-impact-of-type-2-diabetes-mellitus-on-cardiovascular-ri-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007O Stephen Ogedengbe,1 Ignatius U Ezeani,2 Ijezie I Chukwuonye,3 Ndukaife Anyabolu,4,5 Ikemefuna I Ozor,6 Aihanuwa Eregie1 1Department of Internal Medicine, University of Benin Teaching Hospital, Benin City, 2Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Federal Medical Center, Umuahia, 3Division of Nephrology, Department of Internal Medicine, Federal Medical Center, Umuahia, 4Division of Nephrology, Department of Internal Medicine, Imo State University Teaching Hospital, Orlu, 5Division of Nephrology, Department of Internal Medicine, Federal Medical Centre, Owerri, 6Division of Neurosurgery, Department of Surgery, University of Nigeria Teaching Hospital, Enugu, NigeriaBackground: The aim of this study is to evaluate the impact of coexistence of metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) on the estimated cardiovascular risk as calculated using the United Kingdom Prospective Diabetic Study risk engine (UKPDS-RE) and also to determine the impact of the coexistence of MS and T2DM on the 10-year risk of developing coronary heart disease and stroke.Methodology: This is a cross-sectional study in which convenience sampling technique was used to recruit 124 consecutive persons with T2DM and 96 controls using a questionnaire administered technique. The World Health Organization (WHO) criterion was used to define MS and the UKPDS-RE was used to identify persons with increased risk for stroke and those with increased risk for coronary heart disease. The data obtained were analyzed using SPSS version 16. Statistical comparisons were made with chi-square for comparison of proportions. A P-value of less than 0.05 was taken as statistically significant.Results: Fifteen subjects were identified as having an increased 10-year risk for stroke and ten as having an increased risk for a coronary event. The odds of a T2DM subject with MS having an increased risk for stroke compared with a T2DM subject without MS was 0.9579≈1 while the odds of a T2DM subject with MS developing an increased risk for a coronary event compared with a T2DM subject without MS was =3.451≈3.Conclusion: MS was more common in subjects with T2DM compared with controls (irrespective of the diagnostic criteria used) and MS appears to increase the risk of a coronary event in subjects with T2DM by threefold. Also from this study, MS did not appear to cause an additional increase in the risk of stroke in subjects with T2DM.Keywords: diabetes mellitus, metabolic syndrome, coronary heart disease, cardiovascular disease, UKPDS risk engineOgedengbe OSEzeani IUChukwuonye IIAnyabolu ENOzor IIEregie ADove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2015, Iss default, Pp 437-445 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Specialties of internal medicine RC581-951
spellingShingle	Specialties of internal medicine RC581-951 Ogedengbe OS Ezeani IU Chukwuonye II Anyabolu EN Ozor II Eregie A Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
description	O Stephen Ogedengbe,1 Ignatius U Ezeani,2 Ijezie I Chukwuonye,3 Ndukaife Anyabolu,4,5 Ikemefuna I Ozor,6 Aihanuwa Eregie1 1Department of Internal Medicine, University of Benin Teaching Hospital, Benin City, 2Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Federal Medical Center, Umuahia, 3Division of Nephrology, Department of Internal Medicine, Federal Medical Center, Umuahia, 4Division of Nephrology, Department of Internal Medicine, Imo State University Teaching Hospital, Orlu, 5Division of Nephrology, Department of Internal Medicine, Federal Medical Centre, Owerri, 6Division of Neurosurgery, Department of Surgery, University of Nigeria Teaching Hospital, Enugu, NigeriaBackground: The aim of this study is to evaluate the impact of coexistence of metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) on the estimated cardiovascular risk as calculated using the United Kingdom Prospective Diabetic Study risk engine (UKPDS-RE) and also to determine the impact of the coexistence of MS and T2DM on the 10-year risk of developing coronary heart disease and stroke.Methodology: This is a cross-sectional study in which convenience sampling technique was used to recruit 124 consecutive persons with T2DM and 96 controls using a questionnaire administered technique. The World Health Organization (WHO) criterion was used to define MS and the UKPDS-RE was used to identify persons with increased risk for stroke and those with increased risk for coronary heart disease. The data obtained were analyzed using SPSS version 16. Statistical comparisons were made with chi-square for comparison of proportions. A P-value of less than 0.05 was taken as statistically significant.Results: Fifteen subjects were identified as having an increased 10-year risk for stroke and ten as having an increased risk for a coronary event. The odds of a T2DM subject with MS having an increased risk for stroke compared with a T2DM subject without MS was 0.9579≈1 while the odds of a T2DM subject with MS developing an increased risk for a coronary event compared with a T2DM subject without MS was =3.451≈3.Conclusion: MS was more common in subjects with T2DM compared with controls (irrespective of the diagnostic criteria used) and MS appears to increase the risk of a coronary event in subjects with T2DM by threefold. Also from this study, MS did not appear to cause an additional increase in the risk of stroke in subjects with T2DM.Keywords: diabetes mellitus, metabolic syndrome, coronary heart disease, cardiovascular disease, UKPDS risk engine
format	article
author	Ogedengbe OS Ezeani IU Chukwuonye II Anyabolu EN Ozor II Eregie A
author_facet	Ogedengbe OS Ezeani IU Chukwuonye II Anyabolu EN Ozor II Eregie A
author_sort	Ogedengbe OS
title	Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_short	Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_full	Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_fullStr	Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_full_unstemmed	Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
title_sort	evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the ukpds risk engine
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/26deae554b3d40eab6488ab7ac35a9c9
work_keys_str_mv	AT ogedengbeos evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine AT ezeaniiu evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine AT chukwuonyeii evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine AT anyaboluen evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine AT ozorii evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine AT eregiea evaluatingtheimpactoftype2diabetesmellitusoncardiovascularriskinpersonswithmetabolicsyndromeusingtheukpdsriskengine
_version_	1718399801131794432

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine

Ejemplares similares